​

Applied Therapeutics (APLT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Applied Therapeutics Revenue Highlights

Latest Revenue (Y)

$455.00K

0

Main Segment (Y)

Research and Development Services

Applied Therapeutics Revenue by Period

Applied Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$455.00K-95.45%
2023-12-31$9.99M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Applied Therapeutics generated $455.00K in revenue during NA 2024, up -95.45% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Applied Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$-1.00K-100.82%
2024-09-30$122.00K-15.28%
2024-06-30$144.00K-24.21%
2024-03-31$190.00K-128.49%
2023-12-31$-667.00K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$10.66M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Applied Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Applied Therapeutics Revenue Breakdown

Applied Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23
Research and Development Services$455.00K$774.00K
License-$9.22M

Applied Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Research and Development Services (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24
Research and Development Services-$122.00K$190.00K

Applied Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IPHAInnate Pharma$51.90M$16.56M
APLTApplied Therapeutics$455.00K-
ACTUActuate Therapeutics--
MCRBSeres Therapeutics--
FBRXForte Biosciences--
ELTXElicio Therapeutics--
NKTXNkarta--
ANROAlto Neuroscience--
CRDFCardiff Oncology--
MISTMilestone Pharmaceuticals--
ACHVAchieve Life Sciences--

APLT Revenue FAQ

What is Applied Therapeutics’s yearly revenue?

Applied Therapeutics's yearly revenue for 2024 was $455K, representing a decrease of -95.45% compared to 2023. The company's yearly revenue for 2023 was $9.99M, representing an increase of 100.00% compared to 2022. APLT's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Applied Therapeutics’s quarterly revenue?

Applied Therapeutics's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $-1K, a -100.82% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). APLT's quarterly revenue for Q3 2024 was $122K, a -15.28% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Applied Therapeutics’s revenue growth rate?

Applied Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Applied Therapeutics’s revenue streams?

Applied Therapeutics's revenue streams in c 24 are Research and Development Services

What is Applied Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Applied Therapeutics was Research and Development Services. This segment made a revenue of $455K, representing 100.00% of the company's total revenue.